Navigation Links
Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
Date:10/10/2007

COLUMBUS, Ohio, Oct. 10 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Tablets, 150mg, 300mg and 600mg by the U.S. Food and Drug Administration. The product is available in bottles of 100 tablets and Unit Dose Blisters for immediate shipment to wholesalers and pharmacies nationwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' Oxcarbazepine Tablets are AB rated to Trileptal(R) (oxcarbazepine). Annual sales of Oxcarbazepine Tablets 150mg, 300mg and 600mg are approximately $663 Million(1).

Full prescribing information for Oxcarbazepine Tablets is available on the Roxane Laboratories website at http://www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at 1.800.962.8364.

About Roxane Laboratories, Inc.

Roxane Laboratories is located in Columbus, OH in a modern 500,000 square foot manufacturing and laboratory facility. The facility spans 70 acres and currently employs over 1,000 people. Currently, Roxane Laboratories markets over 75 medications in nearly 250 package sizes, focusing on an expanding line of Multisource pharmaceutical products including: bulk and unit-dose liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, cytotoxics and CII narcotics.

Roxane Laboratories, Inc. is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in
'/>"/>

SOURCE Roxane Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Azathioprine 50mg Pills Recalled By FDA And Roxane Labs
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... , WASHINGTON, Nov. 9 /PRNewswire-USNewswire/...tatement praising provisions in the Affordable Hea... improve access to Medicaid and reduce Medicare Pa...962 passed the House on Saturday by a vote of 220 ...roved both health and quality of life for thousand...
(Date:11/9/2009)... , PITTSFIELD, Maine, Nov. 9 ...pients in Maine are increasingly concerned about f...a competitive Medicare option for 2010. ,, The ...ion (PPO) Medicare Advantage plan provides a cost-...l Medicare or a Medicare Supplement plan. People ...
(Date:11/9/2009)... , WASHINGTON, Nov. 9 /PRNewswire-USNewswire/...AAPA), representing more than 75,000 clinically pr...the United States, applauds the U.S. House of Repr...eform bill, H.R. 3962, the Affordable Health Care ...d that this reform bill will ultimately lower the ...
(Date:11/9/2009)... , St. Jude Children,s Research Hospital and the ...e formed a collaboration to provide proton therapy...he approval of the first clinical study to evaluat... in children younger than 3 years old. , Under...ts to receive proton therapy at the UF Proton Ther...
(Date:11/9/2009)... , PHILADELPHIA November 9, 2009 Shire plc (LSE...rmaceutical company, today announced the availabil...ts in pharmacies across the United States for the ...der (ADHD) in children and adolescents ages 6 to 1...e, is the first and only nonscheduled alpha-2A rec...
Breaking Medicine News(10 mins):Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
... Brown & Toland Medical Group,today announced a s...ting,income of $12 million on total revenues of $2...iving approximately $4 million for,pay for perform...s to eligible physicians. In 2007 Brown & Toland,p...
...epressant cut inflammation in relapsing remitting...y News) -- Prozac may help reduce disease activity...ltiple sclerosis (MS), a new study suggests. , For...scans were conducted every four weeks to monitor t...
...seem to cause drop in heart rate variability, rese...ealthDay News) -- Results of a small study show th...s affect the heart rates of newborn babies, Italia...fants who can spend several weeks or months in inc...
...s on outlook for combined entity during its Q1 200..., LISLE, IL, April 30 /PRNewswire-FirstCall/ - SX...(NASDAQ: SXCI , TSX: SXC), a leading provider,of ... acquisition of NMHC by SXC has been completed. SX...
...nly Treatment Approved to Both Reduce Exacerbation... RESEARCH TRIANGLE PARK, N.C., April 30 The,U.S....r Diskus(R) 250/50,(fluticasone propionate 250 mcg...history of exacerbations. With this,approval, Adva...
... Counter to CDC Recommendations, CINCINNATI, Apri... has found that U.S. mothers report they are less ... human papillomavirus virus (HPV),even though the ... for younger daughters, say researchers at Cincinn...
Other Medicine News:Health News:Brown & Toland Announces 2007 Financial Results 2Health News:Prozac Reduces Disease Activity in MS Patients 2Health News:Incubators Affect Newborns' Heart Rates 2Health News:SXC Health Solutions completes acquisition of NMHC 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 2Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 3Health News:Mothers Less Likely to Pursue HPV Vaccination for Youngest Daughters 4
(Date:11/9/2009)...Groundbreaking articles in current issues of Jou...plore, in depth, the emergence of cannabinoid medi... its potential benefits for patients. ,, In the...thors, Sunil Aggarwal, PhD who is a member of the ... who conducted the article,s research and Gregory ...
(Date:11/9/2009)... -- Asthmatx, Inc. presented the results of a seri...safety of bronchial thermoplasty delivered by the ...l impact allergy practices, this past weekend in a... College of Allergy, Asthma and Immunology (ACAAI)...here Could Bronchial Thermoplasty (BT) Fit Into Yo...
(Date:11/9/2009)...MD LASERS just announced that industry leading den...e position of Medical Director. In his new role, ...rch and development of new soft and hard tissue de...ng education credits, authoring articles for relat...ing and seminar engagements. ,, "We are very fo...
Breaking Medicine Technology:Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3AMD LASERS Names Dr. James Jesse as Medical Director 2Swanson Health Products 26apos 3B Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab com 56910 1Swanson Health Products 26apos 3B Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab com 56910 2Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 1Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 2Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 3Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 4Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 5Cardinal Health Announces Early Tender Results of Debt Tender Offer 56907 6Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate 56904 1Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate 56904 2Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate 56904 3
...ntations Include Proof-of-Concept Animal Data on P...lecules TT32 and mAb171, CAMBRIDGE, Mass., Sept. ... data from in vivo disease models on several of th...next week at the XXII,International Complement Wor...l be presented in eight oral and poster,presentati...
...nsdermal Estrogen Analyses Continue to Show Benefi...opausal Women -, MAPLE GROVE, Minn., Sept. 25 Up...clinical abstracts featuring Divigel(R),(estradiol...nopause,Society,s 19th Annual Meeting in Orlando, ...apy that was approved by the FDA in June 2007. It,...
Other Medicine Technology:Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop 2Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop 3New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 2New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 3New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 4
ENDO STITCHtrade; Single-Stitch SOFSILKtrade;
...ient-use instrument designed to assist endoscopica...re and a secure knot intracorporeally -- just push...It is designed for use with the ENDOPATH 5mm troca...ent has two levers: the control lever facilitates ...
ENDOKNOT Suture Type - 0 Coated VICRYL
ENDOLOOP Suture Type - 0 PDSII
Medicine Products: